IP Library Granted Patent US 10,724,949
Granted Patent B2
US 10,724,949 · App. 16/291,145 · Granted Jul 28, 2020

Cuvette for detecting bacteria and determining their susceptibility to antibiotics

Inventor: Amnon Weichselbaum (Haifa, IL)
Assignee: BacterioScan LTD.
G01N21/51B01L3/50B01L3/508C12Q1/04C12Q1/06C12Q1/10C12Q1/18G01N21/03G01N21/49G01N33/4875G01N33/493B01L2300/04B01L2300/0809G01N2015/0693G01N2021/0346G01N2021/0389G01N2021/513
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,949
App. No.
16/291,145
Granted
Jul 28, 2020
Kind
B2
Abstract

A method for detecting and counting particles suspended in fluids, such as bacteria suspended in urine, utilizing dynamic features of the suspended particles and employing light scattering measurements. The disclosed method is suitable for determining the susceptibility of bacteria to antibiotics. A cuvette for detecting bacteria in fluids, which is especially suited for the light scattering measurements, is provided.

Claims (30)

1. A system of determining susceptibility of bacteria to different chemo-effecter agents, comprising:

a light source for generating an input light beam that transmits along an input beam axis;

a first cuvette having a first entry window and a first exit window that are transparent, the first exit window being located on the opposite side of the first cuvette from the first entry window, the first entry window and the first exit window being aligned with the input beam axis, the first cuvette having a first chemo-effecter for mixing with a biological fluid having the bacteria to form a first mixed fluid sample, the first entry window and the first exit window being spaced away from each other with the first mixed fluid sample being present therebetween;

a light detector for receiving light forwardly scattered from the biological fluid in response to being illuminated by the input light beam, the input light beam illuminating a portion of the first mixed fluid sample within the first cuvette to create forward-scattered light exiting the first exit window;

a light-obscuring element located behind the first exit window and in front of the light detector in the direction of the input beam axis, the light-obscuring element being centered on the input beam axis so as to obscure a center portion of the input beam along the input beam axis that exits the first exit the first exit window of the first cuvette such that the light detector receives, over a period of time, a first set of forward-scatter signals associated with the first mixed fluid sample in locations spaced apart from the input beam axis; and

wherein the system is capable of permitting the first cuvette to be replaced by a second cuvette contains a second chemo-effecter agent for forming a second mixed fluid sample when mixed a biological fluid having bacteria for which a second set of forward-scatter signals can be detected by the light detector.

2. The system of claim 1 , further including a temperature regulation system to control temperatures of the first cuvette while receiving the first set of forward-scattered signals.

3. The system of claim 2 , wherein the temperature regulation system induces a temperature gradient in the first fluid sample.

4. The system of claim 1 , further including a filter associated with the first cuvette for filtering the biological fluid prior to placing the biological fluid in the first cuvette.

5. The system of claim 1 , wherein the first set of forward-scattered signals is indicative of a change in concentration level of the bacteria.

6. The system of claim 5 , wherein the change in concentration level of the bacteria indicates the bacterial susceptibility to the first chemo-effector agent.

7. The system of claim 1 , wherein each of the windows has an optical quality defined by a scratch/dig number that is 40/20 or lower.

8. The system of claim 1 , wherein the second chemo-effector agent is different from the first chemo-effector agent.

9. The system of claim 1 , wherein the second chemo-effector agent is the same agent as the first chemo-effector agent, the second chemo-effector agent being at a different concentration than the first chemo-effector agent.

10. The system of claim 1 , wherein the first chemo-effector agent is an antibiotic agent.

11. The system of claim 1 , wherein the first cuvette includes an internal compartment for containing the first chemo-effector agent.

12. The system of claim 1 , wherein the first cuvette includes a removable cover adjacent to the internal compartment.

13. The system of claim 1 , wherein the light source is a laser.

14. A method of determining susceptibility of bacteria to a first chemo-effecter agent by use of a system having a light source for generating an input light beam that transmits along an input beam axis and enters a cuvette containing a biological fluid having the bacteria, the system further having a light detector for receiving light forwardly scattered from the biological fluid, the method comprising:

mixing the biological fluid having the bacteria with a first chemo-effecter agent in a first cuvette to form a first mixed fluid sample, the first cuvette having a first entry window and a first exit window that are transparent, the first exit window being located on the opposite side of the first cuvette from the first entry window, the first entry window and the first exit window being spaced away from each other with the first mixed fluid sample being present therebetween;

aligning the first cuvette in the system such that the first entry window and the first exit window are aligned with the input beam axis of the input light beam;

illuminating a portion of the first mixed fluid sample within the first cuvette with the input light beam to create forward-scattered light exiting the first exit window in locations spaced apart from the the obscuring centered along the input beam axis so as to obscure a center portion of the input beam along the input beam axis that exits the first exit window;

at a location behind the first exit window and in front of the light detector in the direction of the input beam axis, obscuring a remaining portion of the input light beam that exits the first exit window of the first cuvette to inhibit an effect of the input light beam on the light detector, the obscuring centered along the input beam axis so as to obscure a center portion of the input beam along the input beam axis that exits the first exit window;

receiving, over a period of time, a first set of forward-scattered signals at the light detector due to the forward-scattered light from first mixed fluid sample; and

analyzing the first set of forward-scattered signals to determine the susceptibility of the bacteria to the first chemo-effector agent.

15. The method of claim 14 , further including regulating the temperature of the first cuvette while receiving the first set of forward-scattered signals.

16. The method of claim 14 , wherein the biological fluid is urine.

17. The method of claim 14 , wherein the first forward-scattered signal is indicative of a change in concentration level of the bacteria.

18. The method of claim 17 , wherein the change in concentration level of the bacteria indicates the bacterial susceptibility to the first chemo-effector agent.

19. The method of claim 14 , wherein the first chemo-effector agent is an antibiotic agent.

Assignments (3)
LIEN Recorded Jan 18, 2022
From: IP SPECIALISTS LTD
To: MAGHAN ADVISORS LLC
Reel/Frame 058676/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2021
From: BACTERIOSCAN LTD.
To: IP SPECIALISTS LTD
Reel/Frame 054943/0274 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2019
From: WEICHSELBAUM, AMNON
To: BACTERIOSCAN LTD.
Reel/Frame 048512/0292 →
Priority Claims (1)
GB 0615692.1 · Aug 8, 2006 · national
Continuity (7)
Continuation 15949854 · Apr 10, 2018
Continuation 15183969 · Jun 16, 2016
Continuation 14577750 · Dec 19, 2014
Continuation 13689000 · Nov 29, 2012
Division 12085708
Provisional Application 60597395 · Nov 29, 2005
Related Publication 20190195791A1 · Jun 27, 2019